메뉴 건너뛰기




Volumn 13, Issue 3, 2011, Pages 161-173

Juvenile idiopathic arthritis: New insights into classification, measures of outcome, and pharmacotherapy

Author keywords

Abatacept, therapeutic use; Adalimumab, therapeutic use; Anakinra, therapeutic use; Canakinumab, therapeutic use; Children; Corticosteroids, therapeutic use; Disease modifying antirheumatics, therapeutic use; Etanercept, therapeutic use; Infliximab, therapeutic use; Interleukin 1 receptor antagonist, therapeutic use; Juvenile rheumatoid arthritis, treatment; Methotrexate, therapeutic use; Research and development; Tocilizumab, therapeutic use

Indexed keywords

ABATACEPT; ADALIMUMAB; CANAKINUMAB; CORTICOSTEROID; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; PLACEBO; SALAZOSULFAPYRIDINE; TOCILIZUMAB; TRIAMCINOLONE ACETONIDE; TRIAMCINOLONE HEXACETONIDE;

EID: 79955078405     PISSN: 11745878     EISSN: 11792019     Source Type: Journal    
DOI: 10.2165/11588140-000000000-00000     Document Type: Review
Times cited : (26)

References (110)
  • 3
    • 0029917351 scopus 로고    scopus 로고
    • Pediatric rheumatology in the United Kingdom: Data from the British pediatric rheumatology group national diagnostic register
    • Symmons DP, Jones M, Osborne J, et al. Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol 1996; 23 (11): 1975-80 (Pubitemid 26376127)
    • (1996) Journal of Rheumatology , vol.23 , Issue.11 , pp. 1975-1980
    • Symmons, D.P.M.1    Jones, M.2    Osborne, J.3    Sills, J.4    Southwood, T.R.5    Woo, P.6
  • 4
    • 70350455910 scopus 로고    scopus 로고
    • New advances in the management of juvenile idiopathic arthritis: I non-biological therapy
    • Beresford MW, Baildam EM. New advances in the management of juvenile idiopathic arthritis: I. Non-biological therapy. Arch Dis Child Educ Pract Ed 2009; 94 (5): 144-50
    • (2009) Arch. Dis. Child Educ. Pract. Ed. , vol.94 , Issue.5 , pp. 144-150
    • Beresford, M.W.1    Baildam, E.M.2
  • 6
    • 0034096937 scopus 로고    scopus 로고
    • Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis
    • Foeldvari I, Bidde M. Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for Rheumatology. J Rheumatol 2000; 27 (4): 1069-72 (Pubitemid 30389770)
    • (2000) Journal of Rheumatology , vol.27 , Issue.4 , pp. 1069-1072
    • Foeldvari, I.1    Bidde, M.2
  • 7
    • 0035112765 scopus 로고    scopus 로고
    • Classification of chronic arthritides of childhood (juvenile idiopathic arthritis): Criticisms and suggestions to improve the efficacy of the Santiago-Durban criteria [3]
    • Fantini F. Classification of chronic arthritides of childhood (juvenile idiopathic arthritis): criticisms and suggestions to improve the efficacy of the Santiago-Durban criteria. J Rheumatol 2001; 28 (2): 456-9 (Pubitemid 32165171)
    • (2001) Journal of Rheumatology , vol.28 , Issue.2 , pp. 456-459
    • Fantini, F.1
  • 8
    • 0035024702 scopus 로고    scopus 로고
    • Juvenile idiopathic arthritides evaluated prospectively in a single center according to the durban criteria
    • Hofer MF, Mouy R, Prieur AM. Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria. J Rheumatol 2001; 28 (5): 1083-90 (Pubitemid 32422594)
    • (2001) Journal of Rheumatology , vol.28 , Issue.5 , pp. 1083-1090
    • Hofer, M.F.1    Mouy, R.2    Prieur, A.-M.3
  • 9
    • 79955093416 scopus 로고    scopus 로고
    • US Department of health & human services
    • online Available from Mar 2, Accessed
    • US Department of Health & Human Services. US Food and Drug Administration [online]. Available from URL: http://www.fda.gov [Accessed 2011 Mar 2]
    • (2011) US Food and Drug Administration
  • 10
    • 84883519386 scopus 로고    scopus 로고
    • European Medicines Agency Committee forMedicinal Products for Human Use CHMP. CPMP/EWP/422/04 [online]. Available from URL: Accessed Jan 27
    • European Medicines Agency, Committee forMedicinal Products for Human Use (CHMP). Guideline on clinical investigation of medicinal products for the treatment of juvenile idiopathic arthritis. CPMP/EWP/422/04 [online]. Available from URL: http://www.ema.europa.eu/pdfs/human/ewp/042204en.pdf [Accessed 2011 Jan 27]
    • (2011) Guideline on Clinical Investigation of Medicinal Products for The Treatment of Juvenile Idiopathic Arthritis
  • 11
    • 73649102432 scopus 로고    scopus 로고
    • Juvenile idiopathic arthritis: Classification clinical presentation and current treatments
    • 72 Suppl
    • Dannecker GE, Quartier P. Juvenile idiopathic arthritis: classification, clinical presentation and current treatments. Horm Res 2009; 72 Suppl. 1: 4-12
    • (2009) Horm. Res. , vol.1 , pp. 4-12
    • Dannecker, G.E.1    Quartier, P.2
  • 12
    • 33847287323 scopus 로고    scopus 로고
    • Juvenile idiopathic arthritis
    • Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007; 369 (9563): 767-78
    • (2007) Lancet , vol.369 , Issue.9563 , pp. 767-778
    • Ravelli, A.1    Martini, A.2
  • 13
    • 49749135691 scopus 로고    scopus 로고
    • A comprehensive review of the genetics of juvenile idiopathic arthritis abstract
    • Prahalad S, Glass DN. A comprehensive review of the genetics of juvenile idiopathic arthritis [abstract]. Pediatr Rheumatol Online J 2008; 6: 11
    • (2008) Pediatr. Rheumatol. Online J. , vol.6 , pp. 11
    • Prahalad, S.1    Glass, D.N.2
  • 14
    • 77649237975 scopus 로고    scopus 로고
    • Environmental factors and the geoepidemiology of juvenile idiopathic arthritis
    • Berkun Y, Padeh S. Environmental factors and the geoepidemiology of juvenile idiopathic arthritis. Autoimmun Rev 2010; 9 (5): A319-24
    • (2010) Autoimmun. Rev. , vol.9 , Issue.5
    • Berkun, Y.1    Padeh, S.2
  • 15
    • 77950546441 scopus 로고    scopus 로고
    • Possible environmental determinants of juvenile idiopathic arthritis
    • Oxford
    • Ellis JA, Munro JE, Ponsonby AL. Possible environmental determinants of juvenile idiopathic arthritis. Rheumatology (Oxford) 2010; 49 (3): 411-25
    • (2010) Rheumatology , vol.49 , Issue.3 , pp. 411-425
    • Ellis, J.A.1    Munro, J.E.2    Ponsonby, A.L.3
  • 16
    • 0035023255 scopus 로고    scopus 로고
    • Growing pains: The ILAR classification of juvenile idiopathic arthritis
    • Petty RE. Growing pains: the ILAR classification of juvenile idiopathic arthritis. J Rheumatol 2001; 28 (5): 927-8 (Pubitemid 32422567)
    • (2001) Journal of Rheumatology , vol.28 , Issue.5 , pp. 927-928
    • Petty, R.E.1
  • 17
    • 15044365210 scopus 로고    scopus 로고
    • Classification criteria for juvenile idiopathic arthritis in Spanish children
    • Evaluation of revised International League of Associations for Rheumatology Spanish children Edmonton 2001
    • Merino R, de Inocencio J, Garcia-Consuegra J. Evaluation of revised International League of Associations for Rheumatology classification criteria for juvenile idiopathic arthritis in (Edmonton 2001). J Rheumatol 2005; 32 (3): 559-61
    • (2005) J. Rheumatol. , vol.32 , Issue.3 , pp. 559-561
    • Merino, R.1    De Inocencio, J.2    Garcia-Consuegra, J.3
  • 18
    • 33845570843 scopus 로고    scopus 로고
    • Focus on juvenile idiopathic arthritis according to the 2001 Edmonton revised classification from the International League of Associations for Rheumatology: an Italian experience
    • Stabile A, Avallone L, Compagnone A, et al. Focus on juvenile idiopathic arthritis according to the 2001 Edmonton revised classification from the International League of Associations for Rheumatology: an Italian experience. Eur Rev Med Pharmacol Sci 2006; 10 (5): 229-34
    • (2006) Eur. Rev. Med. Pharmacol. Sci. , vol.10 , Issue.5 , pp. 229-234
    • Stabile, A.1    Avallone, L.2    Compagnone, A.3
  • 19
    • 41749123412 scopus 로고    scopus 로고
    • Juvenile idiopathic arthritis: Clinical subgroups and classification
    • 102-6 108-10
    • Minden K, Niewerth M. Juvenile idiopathic arthritis: clinical subgroups and classification. Z Rheumatol 2008; 67 (2): 100, 102-6, 108-10
    • (2008) Z. Rheumatol. , vol.67 , Issue.2 , pp. 100
    • Minden, K.1    Niewerth, M.2
  • 20
    • 33846231470 scopus 로고    scopus 로고
    • Juvenile idiopathic arthritis classification criteria: Loopholes and diagnosis software [3]
    • Behrens EM, Beukelman T, Cron RQ. Juvenile idiopathic arthritis classification criteria: loopholes and diagnosis software. J Rheumatol 2007; 34 (1): 234; author reply 234-5 (Pubitemid 46106593)
    • (2007) Journal of Rheumatology , vol.34 , Issue.1 , pp. 234
    • Behrens, E.M.1    Beukelman, T.2    Cron, R.Q.3
  • 21
    • 54949114697 scopus 로고    scopus 로고
    • HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis
    • Berntson L,Damgard M, Andersson-Gare B, et al. HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis. J Rheumatol 2008; 35 (10): 2055-61
    • (2008) J. Rheumatol. , vol.35 , Issue.10 , pp. 2055-2061
    • Berntson, L.1    Damgard, M.2    Andersson-Gare, B.3
  • 22
    • 67650045888 scopus 로고    scopus 로고
    • Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets
    • Griffin TA, Barnes MG, Ilowite NT, et al. Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets. Arthritis Rheum2009; 60 (7): 2113-23
    • (2009) Arthritis Rheum. , vol.60 , Issue.7 , pp. 2113-2123
    • Griffin, T.A.1    Barnes, M.G.2    Ilowite, N.T.3
  • 23
    • 65849277982 scopus 로고    scopus 로고
    • Early diagnosis of temporomandibular joint involvement in juvenile idiopathic arthritis: A pilot study comparing clinical examination and ultrasound to magnetic resonance imaging
    • Oxford
    • Muller L, Kellenberger CJ, Cannizzaro E, et al. Early diagnosis of temporomandibular joint involvement in juvenile idiopathic arthritis: a pilot study comparing clinical examination and ultrasound to magnetic resonance imaging. Rheumatology (Oxford) 2009; 48 (6): 680-5
    • (2009) Rheumatology , vol.48 , Issue.6 , pp. 680-685
    • Muller, L.1    Kellenberger, C.J.2    Cannizzaro, E.3
  • 24
    • 70449514536 scopus 로고    scopus 로고
    • Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis
    • Magni-Manzoni S, Epis O, Ravelli A, et al. Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis. Arthritis Rheum 2009; 61 (11): 1497-504
    • (2009) Arthritis Rheum. , vol.61 , Issue.11 , pp. 1497-1504
    • Magni-Manzoni, S.1    Epis, O.2    Ravelli, A.3
  • 25
    • 77954429815 scopus 로고    scopus 로고
    • The detection of subclinical synovitis by ultrasound in oligoarticular juvenile idiopathic arthritis: A pilot study
    • Oxford
    • Haslam KE, McCann LJ,Wyatt S, et al. The detection of subclinical synovitis by ultrasound in oligoarticular juvenile idiopathic arthritis: a pilot study. Rheumatology (Oxford) 2010; 49 (1): 123-7
    • (2010) Rheumatology , vol.49 , Issue.1 , pp. 123-127
    • Haslam, K.E.1    McCann, L.J.2    Wyatt, S.3
  • 26
    • 78149258247 scopus 로고    scopus 로고
    • Prospective evaluation of clinical and ultrasound findings in ankle disease in juvenile idiopathic arthritis: Importance of ankle ultrasound
    • Pascoli L, Wright S, McAllister C, et al. Prospective evaluation of clinical and ultrasound findings in ankle disease in juvenile idiopathic arthritis: importance of ankle ultrasound. J Rheumatol 2010; 37 (11): 2409-14
    • (2010) J. Rheumatol. , vol.37 , Issue.11 , pp. 2409-2414
    • Pascoli, L.1    Wright, S.2    McAllister, C.3
  • 27
    • 77954438269 scopus 로고    scopus 로고
    • Synovial and inflammatory diseases in childhood: Role of new imaging modalities in the assessment of patients with juvenile idiopathic arthritis
    • Damasio MB, Malattia C, Martini A, et al. Synovial and inflammatory diseases in childhood: role of new imaging modalities in the assessment of patients with juvenile idiopathic arthritis. Pediatr Radiol 2010; 40 (6): 985-98
    • (2010) Pediatr. Radiol. , vol.40 , Issue.6 , pp. 985-998
    • Damasio, M.B.1    Malattia, C.2    Martini, A.3
  • 28
    • 65649139152 scopus 로고    scopus 로고
    • Evidence-based outcomes of studies addressing diagnostic accuracy of MRI of juvenile idiopathic arthritis
    • Miller E, Uleryk E, Doria AS. Evidence-based outcomes of studies addressing diagnostic accuracy of MRI of juvenile idiopathic arthritis. AJR Am J Roentgenol 2009; 192 (5): 1209-18
    • (2009) AJR Am. J. Roentgenol. , vol.192 , Issue.5 , pp. 1209-1218
    • Miller, E.1    Uleryk, E.2    Doria, A.S.3
  • 29
    • 77953270386 scopus 로고    scopus 로고
    • Imaging juvenile idiopathic arthritis: Assessing the modalities
    • McKay GM, Cox LA, Long BW. Imaging juvenile idiopathic arthritis: assessing the modalities. Radiol Technol 2010; 81 (4): 318-27
    • (2010) Radiol. Technol. , vol.81 , Issue.4 , pp. 318-327
    • McKay, G.M.1    Cox, L.A.2    Long, B.W.3
  • 30
    • 44849099605 scopus 로고    scopus 로고
    • BSPAR position statement on professionals working in paediatric rheumatology
    • DOI 10.1093/rheumatology/ken069
    • Baildam E, Davidson J. BSPAR position statement on professionals working in paediatric rheumatology. Rheumatology (Oxford) 2008; 47 (6): 743-4 (Pubitemid 351796354)
    • (2008) Rheumatology , vol.47 , Issue.6 , pp. 743-744
    • Baildam, E.1    Davidson, J.2
  • 31
    • 77954188304 scopus 로고    scopus 로고
    • BSPAR standards of care for children and young people with juvenile idiopathic arthritis
    • Oxford
    • Davies K, Cleary G, Foster H, et al. BSPAR standards of care for children and young people with juvenile idiopathic arthritis. Rheumatology (Oxford) 2010; 49 (7): 1406-8
    • (2010) Rheumatology , vol.49 , Issue.7 , pp. 1406-1408
    • Davies, K.1    Cleary, G.2    Foster, H.3
  • 32
    • 77954187504 scopus 로고    scopus 로고
    • Developing standards of care for patients with juvenile idiopathic arthritis
    • Oxford
    • Wallace CA. Developing standards of care for patients with juvenile idiopathic arthritis. Rheumatology (Oxford) 2010; 49 (7): 1213-4
    • (2010) Rheumatology , vol.49 , Issue.7 , pp. 1213-1214
    • Wallace, C.A.1
  • 33
    • 72049103194 scopus 로고    scopus 로고
    • Developing outcome measures for paediatric rheumatic diseases
    • Brunner HI, Ravelli A. Developing outcome measures for paediatric rheumatic diseases. Best Pract Res Clin Rheumatol 2009; 23 (5): 609-24
    • (2009) Best. Pract. Res. Clin. Rheumatol. , vol.23 , Issue.5 , pp. 609-624
    • Brunner, H.I.1    Ravelli, A.2
  • 34
    • 34548301943 scopus 로고    scopus 로고
    • Measuring clinical response and remission in juvenile idiopathic arthritis
    • DOI 10.1097/BOR.0b013e32825a6a68, PII 0000228120070900000013
    • Ringold S,Wallace CA. Measuring clinical response and remission in juvenile idiopathic arthritis. Curr Opin Rheumatol 2007; 19 (5): 471-6 (Pubitemid 47344240)
    • (2007) Current Opinion in Rheumatology , vol.19 , Issue.5 , pp. 471-476
    • Ringold, S.1    Wallace, C.A.2
  • 35
    • 4344638042 scopus 로고    scopus 로고
    • International research networks in pediatric rheumatology: The PRINTO perspective
    • DOI 10.1097/01.bor.0000130286.54383.ea
    • Ruperto N, Martini A. International research networks in pediatric rheumatology: the PRINTO perspective. Curr Opin Rheumatol 2004; 16 (5): 566-70 (Pubitemid 39128326)
    • (2004) Current Opinion in Rheumatology , vol.16 , Issue.5 , pp. 566-570
    • Ruperto, N.1    Martini, A.2
  • 37
    • 0012603260 scopus 로고    scopus 로고
    • ACR formally adopts improvement criteria for juvenile arthritis
    • ACR pediatric 30
    • Albornoz MA. ACR formally adopts improvement criteria for juvenile arthritis (ACR pediatric 30). ACR News 2002; 21: 3
    • (2002) ACR News , vol.21 , pp. 3
    • Albornoz, M.A.1
  • 40
    • 0036256812 scopus 로고    scopus 로고
    • Preliminary definition of disease flare in juvenile rheumatoid arthritis
    • BrunnerHI, Lovell DJ, Finck BK, et al. Preliminary definition of disease flare in juvenile rheumatoid arthritis. J Rheumatol 2002; 29 (5): 1058-64 (Pubitemid 34493514)
    • (2002) Journal of Rheumatology , vol.29 , Issue.5 , pp. 1058-1064
    • Brunner, H.I.1    Lovell, D.J.2    Finck, B.K.3    Giannini, E.H.4
  • 41
    • 7544222361 scopus 로고    scopus 로고
    • Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis
    • Wallace CA, Ruperto N, Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004; 31 (11): 2290-4 (Pubitemid 39453253)
    • (2004) Journal of Rheumatology , vol.31 , Issue.11 , pp. 2290-2294
    • Wallace, C.A.1    Ruperto, N.2    Giannini, E.H.3
  • 42
    • 33645833004 scopus 로고    scopus 로고
    • Preliminary validation of clinical remission criteria using the Omeract filter for select categories of juvenile idiopathic arthritis
    • Wallace CA, Ravelli A, Huang B, et al. Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis. J Rheumatol 2006; 33 (4): 789-95
    • (2006) J. Rheumatol. , vol.33 , Issue.4 , pp. 789-795
    • Wallace, C.A.1    Ravelli, A.2    Huang, B.3
  • 43
    • 27744525152 scopus 로고    scopus 로고
    • Patterns of clinical remission in select categories of juvenile idiopathic arthritis
    • DOI 10.1002/art.21389
    • Wallace CA, Huang B, Bandeira M, et al. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 2005; 52 (11): 3554-62 (Pubitemid 41612224)
    • (2005) Arthritis and Rheumatism , vol.52 , Issue.11 , pp. 3554-3562
    • Wallace, C.A.1    Huang, B.2    Bandeira, M.3    Ravelli, A.4    Giannini, E.H.5
  • 44
    • 48349093002 scopus 로고    scopus 로고
    • Abatacept in children with juvenile idiopathic arthritis: A randomised double-blind placebo-controlled withdrawal trial
    • Ruperto N, Lovell DJ, Quartier P, et al. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet 2008; 372 (9636): 383-91
    • (2008) Lancet , vol.372 , Issue.9636 , pp. 383-391
    • Ruperto, N.1    Lovell, D.J.2    Quartier, P.3
  • 45
    • 49549118435 scopus 로고    scopus 로고
    • Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis
    • Magni-Manzoni S, Ruperto N, Pistorio A, et al. Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis. Arthritis Rheum 2008; 59 (8): 1120-7
    • (2008) Arthritis Rheum. , vol.59 , Issue.8 , pp. 1120-1127
    • Magni-Manzoni, S.1    Ruperto, N.2    Pistorio, A.3
  • 46
    • 33846987171 scopus 로고    scopus 로고
    • Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis
    • The Pediatric Rheumatology International Trials Organization Multinational Quality of Life Cohort Study
    • Oliveira S, Ravelli A, Pistorio A, et al. Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis. The Pediatric Rheumatology International Trials Organization Multinational Quality of Life Cohort Study. Arthritis Rheum 2007; 57 (1): 35-43
    • (2007) Arthritis. Rheum. , vol.57 , Issue.1 , pp. 35-43
    • Oliveira, S.1    Ravelli, A.2    Pistorio, A.3
  • 48
    • 0036008765 scopus 로고    scopus 로고
    • The PedsQL™ in pediatric rheumatology: Reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory™ Generic Core Scales and Rheumatology Module
    • DOI 10.1002/art.10095
    • Varni JW, Seid M, Smith KT, et al. The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module. Arthritis Rheum 2002; 46 (3): 714-25 (Pubitemid 34214252)
    • (2002) Arthritis and Rheumatism , vol.46 , Issue.3 , pp. 714-725
    • Varni, J.W.1    Seid, M.2    Knight, T.S.3    Burwinkle, T.4    Brown, J.5    Szer, I.S.6
  • 49
    • 0348161127 scopus 로고    scopus 로고
    • The PedsQL™*4.0 as a pediatric population health measure: Feasibility, reliability, and validity
    • DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2
    • Varni JW, Burwinkle TM, Seid M, et al. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr 2003; 3 (6): 329-41 (Pubitemid 37527280)
    • (2003) Ambulatory Pediatrics , vol.3 , Issue.6 , pp. 329-341
    • Varni, J.W.1    Burwinkle, T.M.2    Seid, M.3    Skarr, D.4
  • 50
    • 66249138135 scopus 로고    scopus 로고
    • Development and validation of a composite disease activity score for juvenile idiopathic arthritis
    • Consolaro A, Ruperto N, Bazso A, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 2009; 61 (5): 658-66
    • (2009) Arthritis Rheum. , vol.61 , Issue.5 , pp. 658-666
    • Consolaro, A.1    Ruperto, N.2    Bazso, A.3
  • 52
    • 41849105404 scopus 로고    scopus 로고
    • The time has come to include assessment of radiographic progression in juvenile idiopathic arthritis clinical trials
    • Ravelli A. The time has come to include assessment of radiographic progression in juvenile idiopathic arthritis clinical trials. J Rheumatol 2008; 35 (4): 553-7 (Pubitemid 351500048)
    • (2008) Journal of Rheumatology , vol.35 , Issue.4 , pp. 553-557
    • Ravelli, A.1
  • 53
    • 42949116861 scopus 로고    scopus 로고
    • Improving the evidence base for treatment of juvenile idiopathic arthritis: The challenge and opportunity facing the MCRN/ARC Paediatric Rheumatology Clinical Studies Group
    • DOI 10.1093/rheumatology/ken055
    • Thornton J, Beresford MW, Clayton P. Improving the evidence base for treatment of juvenile idiopathic arthritis: the challenge and opportunity facing the MCRN/ARC Paediatric Rheumatology Clinical Studies Group. Rheumatology (Oxford) 2008; 47 (5): 563-6 (Pubitemid 351619190)
    • (2008) Rheumatology , vol.47 , Issue.5 , pp. 563-566
    • Thornton, J.1    Beresford, M.W.2    Clayton, P.3
  • 54
    • 10044225800 scopus 로고    scopus 로고
    • Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis
    • Eberhard BA. Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis. J Rheumatol 2004; 31 (12): 2507-12 (Pubitemid 39603105)
    • (2004) Journal of Rheumatology , vol.31 , Issue.12 , pp. 2507-2512
    • Eberhard, B.A.1    Sison, M.C.2    Gottlieb, B.S.3    Ilowite, N.T.4
  • 55
    • 5444237618 scopus 로고    scopus 로고
    • Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: A double-blind trial
    • DOI 10.1093/rheumatology/keh313
    • Zulian F. Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial. Rheumatology (Oxford) 2004; 43 (10): 1288-91 (Pubitemid 39359306)
    • (2004) Rheumatology , vol.43 , Issue.10 , pp. 1288-1291
    • Zulian, F.1    Martini, G.2    Gobber, D.3    Plebani, M.4    Zacchello, F.5    Manners, P.6
  • 56
    • 0141962659 scopus 로고    scopus 로고
    • Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis
    • DOI 10.1093/rheumatology/keg358
    • Zulian F. Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis. Rheumatology (Oxford) 2003; 42(10): 1254-9 (Pubitemid 37258492)
    • (2003) Rheumatology , vol.42 , Issue.10 , pp. 1254-1259
    • Zulian, F.1    Martini, G.2    Gobber, D.3    Agosto, C.4    Gigante, C.5    Zacchello, F.6
  • 57
    • 0036709133 scopus 로고    scopus 로고
    • Treatment of juvenile idiopathic arthritis with intra-articular triamcinolone hexacetonide: Evaluation of clinical effectiveness correlated with circulating ANA and T γ/δ + and B CD5 + lymphocyte populations of synovial fluid
    • Lepore L. Treatment of juvenile idiopathic arthritis with intra-articular triamcinolone hexacetonide: evaluation of clinical effectiveness correlated with circulatingANAand T gamma/delta + and B CD5+ lymphocyte populations of synovial fluid. Clin Exp Rheumatol 2002; 20 (5): 719-22 (Pubitemid 35243789)
    • (2002) Clinical and Experimental Rheumatology , vol.20 , Issue.5 , pp. 719-722
    • Lepore, L.1    Del Santo, M.2    Malorgio, C.3    Presani, G.4    Perticarari, S.5    Prodan, M.6    Di Leo, G.7    Leone, V.8    Tommasini, A.9
  • 58
    • 40049106242 scopus 로고    scopus 로고
    • Factors Influencing the efficacy of intra-articular steroid injections in patients with juvenile idiopathic arthritis
    • DOI 10.1007/s00431-007-0525-9
    • Marti P. Factors influencing the efficacy of intra-articular steroid injections in patients with juvenile idiopathic arthritis. Eur J Pediatr 2008; 167 (4): 425-30 (Pubitemid 351322475)
    • (2008) European Journal of Pediatrics , vol.167 , Issue.4 , pp. 425-430
    • Marti, P.1    Molinari, L.2    Bolt, I.B.3    Seger, R.4    Saurenmann, R.K.5
  • 60
    • 0037374081 scopus 로고    scopus 로고
    • Intra-articular corticosteroid injections in juvenile idiopathic arthritis
    • DOI 10.1136/adc.88.3.192
    • Cleary AG, Murphy HD, Davidson JE. Intra-articular corticosteriod injections in juvenile idiopathic arthritis. Arch Dis Child 2003; 88: 192-6 (Pubitemid 36269496)
    • (2003) Archives of Disease in Childhood , vol.88 , Issue.3 , pp. 192-196
    • Cleary, A.G.1    Murphy, H.D.2    Davidson, J.E.3
  • 62
    • 0026609159 scopus 로고
    • Methotrexate in resistant juvenile rheumatoid arthritis: Results of the USA-USSR double-blind placebo-controlled trial
    • The Pediatric Rheumatology Collaborative Study Group and The Cooperative Childrens Study Group.
    • Giannini EH. Methotrexate in resistant juvenile rheumatoid arthritis: results of the USA-USSR double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Childrens Study Group. N Engl J Med 1992; 326 (16): 1043-9
    • (1992) N. Engl. J. Med. , vol.326 , Issue.16 , pp. 1043-1049
    • Giannini, E.H.1
  • 63
    • 0033875824 scopus 로고    scopus 로고
    • Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis
    • Woo P. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 2000; 43 (8): 1849-57
    • (2000) Arthritis Rheum. , vol.43 , Issue.8 , pp. 1849-1857
    • Woo, P.1
  • 68
    • 77950512831 scopus 로고    scopus 로고
    • Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: A randomized clinical trial
    • Foell D, Wulffraat N, Wedderburn LR, et al. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA 2010; 303 (13): 1266-73
    • (2010) JAMA , vol.303 , Issue.13 , pp. 1266-1273
    • Foell, D.1    Wulffraat, N.2    Wedderburn, L.R.3
  • 69
    • 77649122248 scopus 로고    scopus 로고
    • Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression
    • Hunter PJ, Nistala K, Jina N, et al. Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression. Arthritis Rheum 2010; 62 (3): 896-907
    • (2010) Arthritis Rheum. , vol.62 , Issue.3 , pp. 896-907
    • Hunter, P.J.1    Nistala, K.2    Jina, N.3
  • 72
    • 0035901624 scopus 로고    scopus 로고
    • Rational use of new and existing disease-modifying agents in rheumatoid arthritis
    • Kremer JM. Rational use of new and existing disease-modifying agents in rheumatoid arthritis. Ann Intern Med 2001; 134 (8): 695-706 (Pubitemid 32322246)
    • (2001) Annals of Internal Medicine , vol.134 , Issue.8 , pp. 695-706
    • Kremer, J.M.1
  • 73
    • 34548359264 scopus 로고    scopus 로고
    • Recognition and management of macrophage activation syndrome in juvenile arthritis
    • DOI 10.1097/BOR.0b013e32825a6a79, PII 0000228120070900000014
    • Kelly A,RamananAV. Recognition and management of macrophage activation syndrome in juvenile arthritis. Curr Opin Rheumatol 2007; 19 (5): 477-81 (Pubitemid 47344241)
    • (2007) Current Opinion in Rheumatology , vol.19 , Issue.5 , pp. 477-481
    • Kelly, A.1    Ramanan, A.V.2
  • 74
    • 33751428674 scopus 로고    scopus 로고
    • Autologous haematopoeitic stem cell rescue (AHSCR) for severe rheumatic disease in children: Guidance for BSPAR members - Executive summary
    • DOI 10.1093/rheumatology/kel319a
    • Foster H. Autologous haematopoeitic stem cell rescue (AHSCR) for severe rheumatic disease in children: guidance for BSPAR members. Executive summary. Rheumatology (Oxford) 2006; 45 (12): 1570-1 (Pubitemid 44817067)
    • (2006) Rheumatology , vol.45 , Issue.12 , pp. 1570-1571
    • Foster, H.1    Davidson, J.2    Baildam, E.3    Abinun, M.4    Wedderburn, L.R.5
  • 76
    • 69549155771 scopus 로고    scopus 로고
    • Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK 2000-2007
    • Abinun M, Flood TJ, Cant AJ, et al. Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007). Mol Immunol 2009; 47 (1): 46-51
    • (2009) Mol. Immunol. , vol.47 , Issue.1 , pp. 46-51
    • Abinun, M.1    Flood, T.J.2    Cant, A.J.3
  • 77
    • 70350449256 scopus 로고    scopus 로고
    • New advances in the management of juvenile idiopathic arthritis: II
    • The era of biologicals
    • Beresford MW, Baildam EM. New advances in the management of juvenile idiopathic arthritis: II. The era of biologicals. Arch Dis Child Educ Pract Ed 2009; 94 (5): 151-6
    • (2009) Arch. Dis. Child. Educ. Pract. Ed. , vol.94 , Issue.5 , pp. 151-156
    • Beresford, M.W.1    Baildam, E.M.2
  • 78
    • 33845882484 scopus 로고    scopus 로고
    • Biologic therapies in rheumatology: Lessons learned, future directions
    • DOI 10.1038/nrd2196, PII NRD2196
    • Strand V, Kimberly R, Isaacs JD. Biologic therapies in rheumatology: lessons learned, future directions. Nat Rev Drug Discov 2007; 6 (1): 75-92 (Pubitemid 46020288)
    • (2007) Nature Reviews Drug Discovery , vol.6 , Issue.1 , pp. 75-92
    • Strand, V.1    Kimberly, R.2    Isaacs, J.D.3
  • 79
    • 36549065772 scopus 로고    scopus 로고
    • Biologics for the treatment of juvenile idiopathic arthritis: A systematic review and critical analysis of the evidence
    • DOI 10.1007/s10067-007-0654-6
    • Gartlehner G, Hansen RA, Jonas BL, et al. Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence. Clin Rheumatol 2008; 27 (1): 67-76 (Pubitemid 350182680)
    • (2008) Clinical Rheumatology , vol.27 , Issue.1 , pp. 67-76
    • Gartlehner, G.1    Hansen, R.A.2    Jonas, B.L.3    Thieda, P.4    Lohr, K.N.5
  • 80
    • 55249084910 scopus 로고    scopus 로고
    • Update on biologics in juvenile idiopathic arthritis
    • Ilowite NT. Update on biologics in juvenile idiopathic arthritis. Curr Opin Rheumatol 2008; 20 (5): 613-8
    • (2008) Curr. Opin. Rheumatol. , vol.20 , Issue.5 , pp. 613-618
    • Ilowite, N.T.1
  • 81
    • 77955371398 scopus 로고    scopus 로고
    • Tumor necrosis factor alpha blockers and malignancy in children: Forty-eight cases reported to the food and drug administration
    • Diak P, Siegel J, La GL, et al. Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration. Arthritis Rheum 2010; 62 (8): 2517-24
    • (2010) Arthritis Rheum. , vol.62 , Issue.8 , pp. 2517-2524
    • Diak, P.1    Siegel, J.2    La, G.L.3
  • 82
    • 77955385352 scopus 로고    scopus 로고
    • Should the Food and Drug Administration warning of malignancy in children receiving tumor necrosis factor alpha blockers change the way we treat children with juvenile idiopathic arthritis
    • Lehman TJ. Should the Food and Drug Administration warning of malignancy in children receiving tumor necrosis factor alpha blockers change the way we treat children with juvenile idiopathic arthritis? Arthritis Rheum 2010; 62 (8): 2183-4
    • (2010) Arthritis Rheum. , vol.62 , Issue.8 , pp. 2183-2184
    • Lehman, T.J.1
  • 83
    • 77953340599 scopus 로고    scopus 로고
    • Summary of worldwide pediatric malignancies reported after exposure to etanercept
    • McCroskery P, Wallace CA, Lovell DJ, et al. Summary of worldwide pediatric malignancies reported after exposure to etanercept. Pediatr Rheumatol Online J 2010; 8: 18
    • (2010) Pediatr. Rheumatol. Online J. , vol.8 , pp. 18
    • McCroskery, P.1    Wallace, C.A.2    Lovell, D.J.3
  • 84
    • 34250651691 scopus 로고    scopus 로고
    • Biologic therapies in juvenile idiopathic arthritis: Why and for whom
    • McCann LJ, Woo P. Biologic therapies in juvenile idiopathic arthritis: why and for whom? Acta Reumatol Port 2007; 32 (1): 15-26
    • (2007) Acta. Reumatol. Port. , vol.32 , Issue.1 , pp. 15-26
    • McCann, L.J.1    Woo, P.2
  • 85
    • 41649084155 scopus 로고    scopus 로고
    • At the horizon of innovative therapy in rheumatology: New biologic agents
    • DOI 10.1097/BOR.0b013e3282fa13b4, PII 0000228120080500000008
    • Finckh A. At the horizon of innovative therapy in rheumatology: new biologic agents. Curr Opin Rheumatol 2008; 20 (3): 269-75 (Pubitemid 351483315)
    • (2008) Current Opinion in Rheumatology , vol.20 , Issue.3 , pp. 269-275
    • Finckh, A.1    Gabay, C.2
  • 87
    • 49949115223 scopus 로고    scopus 로고
    • Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
    • Lovell DJ, Ruperto N, Goodman S, et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 2008; 359 (8): 810-20
    • (2008) N. Engl. J. Med. , vol.359 , Issue.8 , pp. 810-820
    • Lovell, D.J.1    Ruperto, N.2    Goodman, S.3
  • 91
    • 66149142293 scopus 로고    scopus 로고
    • Long-term follow-up on effectiveness and safety of etanercept in JIA: The Dutch national register
    • Prince FH. Long-term follow-up on effectiveness and safety of etanercept in JIA: the Dutch national register. Ann Rheum Dis 2009; 68 (5): 635-41
    • (2009) Ann. Rheum. Dis. , vol.68 , Issue.5 , pp. 635-641
    • Prince, F.H.1
  • 92
    • 65249098979 scopus 로고    scopus 로고
    • Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis JIA: Preliminary data from the german jia registry
    • Horneff G. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Ann Rheum Dis 2009; 68 (4): 519-25
    • (2009) Ann. Rheum. Dis. , vol.68 , Issue.4 , pp. 519-525
    • Horneff, G.1
  • 94
    • 13444310439 scopus 로고    scopus 로고
    • Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor α monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: Results of an open-label prospective study
    • DOI 10.1002/art.20793
    • Gerloni V. Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study. Arthritis Rheum 2005; 52 (2): 548-53 (Pubitemid 40216319)
    • (2005) Arthritis and Rheumatism , vol.52 , Issue.2 , pp. 548-553
    • Gerloni, V.1    Pontikaki, I.2    Gattinara, M.3    Desiati, F.4    Lupi, E.5    Lurati, A.6    Salmaso, A.7    Fantini, F.8
  • 95
    • 0037370938 scopus 로고    scopus 로고
    • Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: An open label study
    • DOI 10.1136/ard.62.3.245
    • Lahdenne P. Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study. Ann Rheum Dis 2003; 62 (3): 245-7 (Pubitemid 36238089)
    • (2003) Annals of the Rheumatic Diseases , vol.62 , Issue.3 , pp. 245-247
    • Lahdenne, P.1    Vahasalo, P.2    Honkanen, V.3
  • 98
    • 62949147825 scopus 로고    scopus 로고
    • online Available from URL Accessed Feb 9
    • European Medicines Agency [online]. Available from URL: www.ema.europa.eu/ema [Accessed 2011 Feb 9]
    • (2011) European Medicines Agency
  • 99
    • 31544465967 scopus 로고    scopus 로고
    • Systemic juvenile idiopathic arthritis: Diagnosis, management, and outcome
    • DOI 10.1038/ncprheum0084, PII N0084
    • Woo P. Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome. Nat Clin Pract Rheumatolol 2006; 2 (1): 28-34 (Pubitemid 43153646)
    • (2006) Nature Clinical Practice Rheumatology , vol.2 , Issue.1 , pp. 28-34
    • Woo, P.1
  • 100
    • 31544451391 scopus 로고    scopus 로고
    • Open label phase II trial of single ascending doses ofMRAin Caucasian children with severe systemic juvenile idiopathic arthritis: Proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement
    • Woo P.Open label phase II trial of single, ascending doses ofMRAin Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Res Ther 2005; 7 (6): R1281-8
    • (2005) Arthritis Res. Ther. , vol.7 , Issue.6
    • Woo, P.1
  • 103
    • 39549120448 scopus 로고    scopus 로고
    • Anakinra treatment for systemic juvenile idiopathic arthritis and adult onset Still disease
    • DOI 10.1136/ard.2007.082859
    • Woo P. Anakinra treatment for systemic juvenile idiopathic arthritis and adult onset Still disease. Ann Rheum Dis 2008; 67 (3): 281-2 (Pubitemid 351281258)
    • (2008) Annals of the Rheumatic Diseases , vol.67 , Issue.3 , pp. 281-282
    • Woo, P.1
  • 104
    • 43049158200 scopus 로고    scopus 로고
    • Anakinra treatment for systemic onset juvenile idiopathic arthritis SOJIA
    • Oxford
    • Ohlsson V. Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA). Rheumatology (Oxford) 2008; 47 (4): 555-6
    • (2008) Rheumatology , vol.47 , Issue.4 , pp. 555-556
    • Ohlsson, V.1
  • 109
    • 11344266825 scopus 로고    scopus 로고
    • Treating children with arthritis: Towards an evidence-based culture
    • Feldman BM. Treating children with arthritis: towards an evidence-based culture. J Rheumatol Suppl 2005; 72: 33-5 (Pubitemid 40075951)
    • (2005) Journal of Rheumatology , vol.32 , Issue.SUPPL. 72 , pp. 33-35
    • Feldman, B.M.1
  • 110
    • 79955097117 scopus 로고    scopus 로고
    • online Available from URL; Accessed Feb 9
    • Medicines for Children Research Network [online]. Available from URL: http://mcrn.org.uk [Accessed 2011 Feb 9]
    • (2011) Medicines for Children Research Network


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.